1dlb: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1dlb.gif|left|200px]]
{{Seed}}
[[Image:1dlb.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1dlb|  PDB=1dlb  |  SCENE=  }}  
{{STRUCTURE_1dlb|  PDB=1dlb  |  SCENE=  }}  


'''HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES'''
===HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES===




==Overview==
<!--
The HIV-1 gp41 envelope protein mediates membrane fusion that leads to virus entry into the cell. The core structure of fusion-active gp41 is a six-helix bundle in which an N-terminal three-stranded coiled coil is surrounded by a sheath of antiparallel C-terminal helices. A conserved glutamine (Gln 652) buried in this helical interface replaced by leucine increases HIV-1 infectivity. To define the basis for this enhanced membrane fusion activity, we investigate the role of the Gln 652 to Leu substitution on the conformation, stability, and biological activity of the N34(L6)C28 model of the gp41 ectodomain core. The 2.0 A resolution crystal structure of the mutant molecule shows that the Leu 652 side chains make prominent contacts with hydrophobic grooves on the surface of the central coiled coil. The Gln 652 to Leu mutation leads to a marginal stabilization of the six-helix bundle by -0.8 kcal/mol, evaluated from thermal unfolding experiments. Strikingly, the mutant N34(L6)C28 peptide is a potent inhibitor of HIV-1 infection, with 10-fold greater activity than the wild-type molecule. This inhibitory potency can be traced to the corresponding C-terminal mutant peptide that likely has greater potential to interact with the coiled-coil trimer. These results provide strong evidence that conserved interhelical packing interactions in the gp41 core are important determinants of HIV-1 entry and its inhibition. These interactions also offer a test-bed for the development of more potent analogues of gp41 peptide inhibitors.
The line below this paragraph, {{ABSTRACT_PUBMED_10677212}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 10677212 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_10677212}}


==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Membrane fusion]]
[[Category: Membrane fusion]]
[[Category: Virus/viral protein]]
[[Category: Virus/viral protein]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 13:58:54 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 23:14:42 2008''

Revision as of 23:14, 30 June 2008

File:1dlb.png

Template:STRUCTURE 1dlb

HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDESHELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES

Template:ABSTRACT PUBMED 10677212

About this StructureAbout this Structure

1DLB is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

ReferenceReference

Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides., Shu W, Liu J, Ji H, Radigen L, Jiang S, Lu M, Biochemistry. 2000 Feb 22;39(7):1634-42. PMID:10677212

Page seeded by OCA on Mon Jun 30 23:14:42 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA